Literature DB >> 25703620

The relationship between neuropsychological functioning and FDG-PET hypometabolism in intractable mesial temporal lobe epilepsy.

Alex A Knopman1, Chong H Wong2, Richard J Stevenson3, Judi Homewood3, Armin Mohamed4, Ernest Somerville5, Stefan Eberl4, Lingfeng Wen4, Michael Fulham4, Andrew F Bleasel6.   

Abstract

We examined the relationship between baseline neuropsychological functioning and 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in intractable mesial temporal lobe epilepsy (MTLE). We hypothesized relationships between dominant temporal lobe hypometabolism and verbal memory and between nondominant temporal lobe hypometabolism and nonverbal memory in line with the lateralized material-specific model of memory deficits in MTLE. We also hypothesized an association between performance on frontal lobe neuropsychological tests and prefrontal hypometabolism. Thirty-two patients who had undergone temporal lobectomy for treatment of MTLE and who completed both presurgical FDG-PET and comprehensive neuropsychological investigations with widely used standardized measures were included. Age-adjusted composite measures were calculated for verbal memory, nonverbal memory, relative material-specific memory, IQ, executive function, attention/working memory, and psychomotor speed. Fluorodeoxyglucose positron emission tomography was analyzed with statistical parametric mapping (SPM) to identify hypometabolism relative to healthy controls. Pearson's correlation was used to determine the relationship between regions of hypometabolism and neuropsychological functioning. Dominant temporal lobe hypometabolism was associated with relatively inferior verbal memory, while nondominant temporal lobe hypometabolism was associated with inferior nonverbal memory. No relationship was found between performance on any frontal lobe measures and prefrontal hypometabolism. Statistical parametric mapping-quantified lateralized temporal lobe hypometabolism correlates with material-specific episodic memory impairment in MTLE. In contrast, prefrontal hypometabolism is not associated with performance on frontal lobe measures. We suggest that this is because frontal lobe neuropsychology tests may not be good measures of isolated frontal lobe functioning.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive functioning; Epilepsy surgery; Episodic memory; Focal epilepsy; Frontal lobes; Positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 25703620     DOI: 10.1016/j.yebeh.2015.01.023

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Changes of biochemical biomarkers in the serum of children with convulsion status epilepticus: a prospective study.

Authors:  Manli Wang; Jian Yu; Xiao Xiao; Bingbing Zhang; Jihong Tang
Journal:  BMC Neurol       Date:  2022-05-27       Impact factor: 2.903

Review 2.  Multimodal neuroimaging computing: a review of the applications in neuropsychiatric disorders.

Authors:  Sidong Liu; Weidong Cai; Siqi Liu; Fan Zhang; Michael Fulham; Dagan Feng; Sonia Pujol; Ron Kikinis
Journal:  Brain Inform       Date:  2015-08-29

Review 3.  Multimodal neuroimaging computing: the workflows, methods, and platforms.

Authors:  Sidong Liu; Weidong Cai; Siqi Liu; Fan Zhang; Michael Fulham; Dagan Feng; Sonia Pujol; Ron Kikinis
Journal:  Brain Inform       Date:  2015-09-04

Review 4.  Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology.

Authors:  Marion Bankstahl; Jens P Bankstahl
Journal:  Front Vet Sci       Date:  2017-12-13

5.  Correlation of neuropsychological and metabolic changes after epilepsy surgery in patients with left mesial temporal lobe epilepsy with hippocampal sclerosis.

Authors:  Canan Güvenç; Patrick Dupont; Jan Van den Stock; Laura Seynaeve; Kathleen Porke; Eva Dries; Karen Van Bouwel; Johannes van Loon; Tom Theys; Karolien E Goffin; Wim Van Paesschen
Journal:  EJNMMI Res       Date:  2018-04-12       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.